Role of Surfactant Protein-C Mutation and Ozone Exposure in the Exacerbation of Pulmonary Fibrosis
Role of Surfactant Protein-C Mutation and Ozone Exposure in the Exacerbation of Pulmonary Fibrosis
批准号:
10116659
负责人:
ALESSANDRO VENOSA
金额:
$53.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-02-01 至 2025-11-30
关键词:
AcuteAir PollutantsBleomycinCellsCessation of lifeChemical InjuryClinicalDataDegenerative DisorderDependenceDiagnosisDiseaseEctopic ExpressionEnvironmental ExposureEnvironmental Risk FactorEpidemiologyEpithelialEpithelial CellsFibrosisFlow CytometryFutureGenesGeneticGenetic TranscriptionHealthHeterogeneityHistologicHistologyHumanInflammationInflammatoryInflammatory ResponseInhalationInjuryLesionLife ExpectancyLinkLungLung InflammationLung TransplantationLung diseasesMediator of activation proteinMethodsModelingMutant Strains MiceMutationMyeloid Cell ActivationMyeloid CellsOxidative StressOzonePathogenesisPatientsPeripheralPharmacologyPhenotypePopulationPre-Clinical ModelPropertyPublishingPulmonary FibrosisPulmonary InflammationPulmonary Surfactant-Associated Protein CRoleSeveritiesSignal TransductionSolidSystemTestingTimeTissuesToxic Environmental SubstancesToxic effectVulnerable PopulationsWorkchemokine receptorclinically relevantcytokineeffective therapyfibrogenesisfractalkine receptorimprovedinformation modelinjuredmacrophagemonocytemouse modelmutantnovelozone exposurerecruitresponsesingle-cell RNA sequencingtranscriptome sequencingventilation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract:
Pulmonary fibrosis (PF) is a rare degenerative disease characterized by progressive lung stiffening, resulting in
death within 3-5 years of diagnosis. Compelling clinical evidence show that mutations of the epithelial cell-
specific gene encoding surfactant protein-C (SP-C), are linked to a particularly extreme lung phenotype.
Progression of PF in humans is often punctuated by inflammatory bursts, clinically termed “acute exacerbations”,
that drastically accelerate the disease and reduce life expectancy. In accord with this notion, monocyte
mobilization and the persistence of monocyte-derived macrophages in the lung are strong predictors of PF
severity. Several environmental factors have been proposed to promote and accelerate acute inflammatory
exacerbations of PF; however, the exact mechanisms have not been interrogated. The ubiquitous air pollutant
ozone (O3) represents a major, and unavoidable, environmental contributor to pulmonary disease through
oxidative stress and monocyte/macrophage rich inflammation. To closely mimic causes of human PF, we
developed a novel mouse model that develops spontaneous lesions over time, as a result of inducible ectopic
expression of the most common PF-linked SP-C mutation (SP-CI73T). This preclinical model provides a unique
platform to decipher mechanisms of PF progression and specifically the roles of acute exacerbations (induced
by O3), infiltrating monocytes, and monocyte-derived macrophages in promoting PF. Our published work showed
that SP-C mutation is accompanied by a dynamic monocyte/macrophage inflammatory response, initiated by
the epithelium. Preliminary evidence confirm that O3 exposure amplifies inflammatory cell influx and pro-
inflammatory signaling in SP-C mutant mice, worsening PF. Assessment of the proposed paradigm will provide
fundamental data to define the responses of the healthy, acutely inflamed, and fully fibrotic lung to environmental
exposure. Our hypothesis is that O3-induced acute exacerbation of PF driven by SP-C mutation enhances the
recruitment and activation of inflammatory monocytes, triggering a monocyte-derived macrophage pro-fibrotic
response. Our Specific Aims are to: 1) Define monocyte dynamics following O3-induced pulmonary inflammation
and PF. 2) Investigate the role of monocyte-derived macrophages and O3-induced exacerbation of PF; and 3) :
Establish the role of monocyte subpopulations in the PF phenotype.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Surfactant Protein-C Mutation and Ozone Exposure in the Exacerbation of Pulmonary Fibrosis
-
批准号:10529337
-
项目类别:
-
资助金额:$38.32万
-
财政年份:2021
-
负责人:ALESSANDRO VENOSA
-
依托单位:
Role of Surfactant Protein-C Mutation and Ozone Exposure in the Exacerbation of Pulmonary Fibrosis
-
批准号:10331034
-
项目类别:
-
资助金额:$38.01万
-
财政年份:2021
-
负责人:ALESSANDRO VENOSA
-
依托单位:
海外基金